Course series
An evidence-based guide to testosterone therapy use in women, from its one supported indication, HSDD in postmenopausal women, to formulation selection, monitoring, and safe prescribing.
Course Available from $95
Testosterone has become a wellness buzzword, marketed to women for energy, mood, muscle, and libido despite limited and inconsistent evidence for most of these claims. Patients are increasingly asking for it, yet many clinicians lack a clear framework for evaluating those requests. At the same time, hypoactive sexual desire disorder (HSDD) in postmenopausal women, the one indication the evidence supports, often goes under-recognized. This course equips you to tell the difference and prescribe appropriately when testosterone is indicated.
You’ll start with the physiology: where testosterone comes from in women and its role as a precursor to estradiol. Then you’ll learn to identify HSDD as the evidence-based indication, compare available formulations and why transdermal dosing is generally preferred, and apply a practical approach to informed consent, baseline and follow-up testing, side effects, safety considerations, and contraindications. A clinical case and a review of common myths put it all into practice.
After participating in this activity, learners will be able to:
Meet the team
Chief Medical Officer
Dr. Robin Noble moved from general obstetric care into a practice focused entirely on gynecology, fertility, and midlife women’s health, with particular clinical interest in the menopause transition, pelvic pain, and sexual function.
She oversees and guides EncorVita’s clinical strategy and educational content.
Sr. Director of Medical Affairs
Laura Abrignani, NP, MSN, MSCP, brings 30+ years in women’s health and menopause care, plus 17 years leading Medical Affairs at Bayer, Allergan and Conceptus. Harbor-UCLA trained, she joined EncorVita to help close the menopause care gap for women and the providers who serve them.
Medical Writer
Michelle Nezolosky, MPH brings over 10 years of experience in women’s health, clinical research, and medical education. Former Director at HerMD, with research training at Harvard-affiliated Dana-Farber, she combines research expertise and health communications to develop evidence-based education.
In support of improving patient care, this activity has been planned and implemented by EncorVita™ Health and Pinnacle Conference, LLC. Pinnacle Conference, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Clinicians caring for women in midlife, including physicians, nurse practitioners, physician assistants, dietitians, nurses, and pharmacists in primary care, women’s health, and beyond, who evaluate, counsel, or manage women considering testosterone therapy, or who field patient requests for it.
0.5 CE credits. Through Pinnacle Conference, LLC (Joint Accreditation), the activity offers credit for physicians (AMA PRA Category 1 Credit™), nurses (ANCC contact hours), pharmacists (ACPE), physician assistants (AAPA Category 1), dietitians (CDR CPEUs), dentists (ADA CERP), athletic trainers (BOC), and Interprofessional Continuing Education (IPCE). Nurse practitioners can apply AMA PRA Category 1 Credit™ through AANP.
The course takes about 30 minutes, and you can complete it on your own schedule. Credit is available through September 21, 2029.
Yes. A knowledge assessment with a minimum passing score of 80% and a brief activity evaluation are required to earn credit and receive your certificate.
No. This course stands on its own and gives you an evidence-based foundation in testosterone therapy for women, whether you’re just starting to field patient questions about testosterone or already prescribing it.
No. There is currently no FDA-approved testosterone product for women in the United States, so clinical use is off-label. The course covers what that means in practice, including informed consent and setting realistic expectations with patients.
Yes. The course reviews the full range of available formulations, including pellets, injections, and compounded preparations, and explains which are recommended and why. It focuses on evidence and safety, including why transdermal dosing is generally preferred. It does not provide dosing or procedural instruction for formulations that aren’t recommended, such as pellet insertion.
Not Just a Male Hormone: The Case for Testosterone in Women – EncorVita™ Health
Activity Date: September 21, 2026 – September 21, 2029
Activity Type: Enduring
Activity Website: https://academy.encorvita.com/
CE: 0.5 total credits
JA-PARS Activity ID: 203758449
ACPE UAN – Pharmacists: UAN JA4008385-9999-26-096-H01-P
ACPE UAN – Pharmacy Technicians: UAN JA4008385-9999-26-096-H01-T
This activity offers 0.5 CE credit(s) for:
1. Physicians (AMA PRA Category 1 Credit™)
2. Nurses (ANCC NCPD)
3. Pharmacists (ACPE CPE)
4. Physician Assistants (AAPA Category 1)
5. Dietitians (CDR CPEUs)
6. Dentists (ADA-CERP CE)
7. Athletic Trainers (BOC CEUs)
8. Interprofessional Continuing Education (IPCE)
9. Other*
*All other attendees will receive an AMA PRA Category 1 Credit™ participation certificate
This activity was planned by, and for, the interprofessional healthcare team.
This enduring activity focuses on providing licensed healthcare clinicians with an evidence-based framework for evaluating and, when appropriate, prescribing testosterone therapy in women. Learners will review the physiologic sources and role of testosterone in women, identify the evidence-based indication of hypoactive sexual desire disorder (HSDD) in postmenopausal women, distinguish supported clinical use from unsupported wellness claims, and recognize common misconceptions surrounding testosterone therapy. The activity is delivered through a self-paced online video presentation with a structured didactic component and embedded knowledge assessment. Content addresses available testosterone formulations, the preference for transdermal dosing over oral, pellet, or injectable routes, appropriate testing and monitoring, side effects, safety considerations, contraindications, and application of evidence-based guidance to clinical cases. Participants should complete the educational presentation and knowledge assessment and consider how the information can be applied to their clinical practice. Successful completion of the knowledge assessment and activity evaluation is required to complete the activity and receive the certificate.
Testosterone has become increasingly prominent in wellness discussions and is often marketed for benefits such as energy, mood, muscle, and libido, despite limited and inconsistent evidence for many of these claims. Clinicians need clear, evidence-based guidance to distinguish the supported indication of HSDD in postmenopausal women from broader wellness claims and requests they may encounter in practice. A key practice gap is that many clinicians lack a clear framework for evaluating requests for testosterone therapy. Patients may be exposed to wellness marketing that overstates potential benefits, creating pressure to prescribe testosterone for indications that are not supported by the evidence, while clinicians may also under-recognize HSDD as the evidence-based indication.
This activity is suitable for Physicians, Nurses, Pharmacists, Physician Assistants, Dietitians, Dentists, Athletic Trainers, and other healthcare professionals involved in patient care.
The activity is particularly relevant to licensed healthcare clinicians caring for women in midlife, including nurse practitioners, physician assistants, registered nurses, and physicians who are involved in evaluating, counseling, or managing women considering testosterone therapy.
It is the policy of Pinnacle Conference, LLC, to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. Pinnacle Conference, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Robin Noble, MD, MHCDS, MSCP, has disclosed several financial relationships: Chief Medical Officer, Equity, Consulting at EncorVita Health; Medical Advisor, Equity, Consulting at Play Health; Chief Medical Advisor, Equity, Consulting at Mia Health; Equity, Consultant at Indagare; Chief Medical Advisor at Let’s Talk Menopause; Advisory Board, Equity at Bioceptive; Advisory Board, Equity at GYNtle; Advisory Board, Equity at Immugen; Advisory at DrKumo; Board Member, Shareholder Physician at Intermed, PA.
Laura Abrignani, NP, MSN, MSCP, has disclosed several financial relationships: Speaker at Bayer Healthcare; Sr. Director, Medical Affairs at EncorVita Health.
Michelle Nezolosky, MPH, has disclosed several financial relationships: Independent Contractor at EncorVita Health; Independent Contractor at Eterna, Inc.; Employee at HerMD.
Robin Noble, MD, MHCDS, MSCP, has disclosed several financial relationships: Chief Medical Officer, Equity, Consulting at EncorVita Health; Medical Advisor, Equity, Consulting at Play Health; Chief Medical Advisor, Equity, Consulting at Mia Health; Equity, Consultant at Indagare; Chief Medical Advisor at Let’s Talk Menopause; Advisory Board, Equity at Bioceptive; Advisory Board, Equity at GYNtle; Advisory Board, Equity at Immugen; Advisory at DrKumo; Board Member, Shareholder Physician at Intermed, PA.
Laura Abrignani, NP, MSN, MSCP, has disclosed several financial relationships: Speaker at Bayer Healthcare; Sr. Director, Medical Affairs at EncorVita Health.
Michelle Nezolosky, MPH, has disclosed several financial relationships: Independent Contractor at EncorVita Health; Independent Contractor at Eterna, Inc.; Employee at HerMD.
Pamela Mehta, MD, has nothing to disclose.
Shafqat Abbas, PharmD, has nothing to disclose.
All relevant financial relationships have been evaluated and mitigated.
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. Pinnacle Conference, LLC, the faculty, planners, and EncorVita™ Health do not endorse the use of any product outside of the FDA-labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
In support of improving patient care, this activity has been planned and implemented by EncorVita™ Health and Pinnacle Conference, LLC. Pinnacle Conference, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Pinnacle Conference, LLC, designates this Enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 Credits™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from Jointly Accredited Organizations. Nurse practitioners can also apply for credit through their state boards.
This activity is designated for 0.5 contact hours.
To receive CPE credit through CPE Monitor, please ensure you have provided your NABP ePID number and DOB appropriately. If you are unsure or would like to confirm, please contact ce@learnatpinnacle.com within 60 days of completing the activity.
Pinnacle Conference, LLC has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Pinnacle Conference, LLC (BOC AP#: JA4008385) is approved by the Board of Certification, Inc. to provide continuing education to Athletic Trainers (ATs). This program is eligible for a maximum of (0.5) Category A hours/CEUs. ATs should claim only those hours actually spent in the educational program.
Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (1 IPCE credits = 1 CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (1 hour/60 minutes = 1 CPEU). RDs and DTRs are to select activity type 102 in their Activity Logs. Performance Indicator selection is at the learner’s discretion.
Pinnacle Conference, LLC is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP. Pinnacle Conference, LLC designates this activity for 0.5 hours continuing education credits. Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credits for learning and change.
Enroll now to purchase and get started.
The clinical resources menopause didn’t have – until now
CE Course
NEW!
CE Course
NEW!
CE Course
CE Course
CE Course
No courses match that category yet.
